Rentschler Biopharma

From all of us at Rentschler Biopharma, we wish you and your loved ones a wonderful festive season filled with peace, joy and health. The children from our Day Care Center in Laupheim had a lot of fun painting this wintery picture just for you.

Last week, we were honored to welcome Martin Gerster, member of the German Federal Parliament, and his employee Maria Brumme, to our headquarters in Laupheim, Germany.   During his visit, we engaged in meaningful discussions about the significant impact biotech companies like Rentschler Biopharma have on society, the economy, and the community – as key producers of life-saving biopharmaceuticals. The lab tour offered an insightful glimpse into the complex journey of biopharmaceutical development and manufacturing, from concept to market.   We were delighted to have our Chief Operating Officer, Christiane Bardroff; Head of Process Science and Analytical Science, Thilo Grob; and Global Head of Communications, Dr. Latika Bhonsle-Deeng, host this meaningful exchange.   Learn more about our work and our latest developments here: https://lnkd.in/dNvwGa5   #StarkamStandort #biopharmaceuticals #cdmo

In collaboration with Refeyn and the Cell and Gene Therapy Catapult and supported by Innovate UK, we have developed a rapid, small-scale purification process that revolutionizes AAV production. Find our more from our colleagues Nathan Sweeney and Hena Divanovic.

Biopharmaceutical products are often produced in Chinese hamster ovary (CHO) cell cultures, which release retrovirus-like particles and are vulnerable to infections by adventitious viruses. Therefore, it is a regulatory requirement that downstream purification steps for biopharmaceuticals can remove viruses from feedstocks. In his article “Mechanistic modeling of minute virus of mice surrogate removal by anion exchange chromatography in micro scale”, published in Journal of Chromatography A, Lukas Döring, our Doctoral Researcher Process Science – in collaboration with Johannes Winderl, our Process Manager Process Science, Matthias Kron, our Senior Director Process Science Downstream of Rentschler Biopharma and Professor Jürgen Hubbuch from the Karlsruhe Institute of Technology – discusses how the virus clearance of a MVM mock virus particle by Q Sepharose FF resin can be accurately described by mechanistic modeling.  

At Rentschler Biopharma, we believe that every individual deserves to live with dignity, respect, and equality. On this Human Rights Day, and as a signatory of the UN Global Compact, we reaffirm our commitment to upholding these fundamental rights in every aspect of our work. “We are proud to contribute to global healthcare and to enable every person to have the right to access medical care,” says Maximilian Ludwig our Sustainability Officer. Together, let’s continue to champion human rights, foster inclusive environments, and advance medicine to save lives.  #RentschlerBiopharma #HumanRightsDay #Equality #StandUpForRights #Inclusion 

How did we get from GMP to PPQ in just 12 months? Find out in this white paper by our colleagues Jessica Feldman, PhD and Henning Gerschewski. What a great team effort!

It was a pleasure to welcome a delegation of Danish start-ups to our headquarters last week. The visit was part of a BioTech tour of Southern Germany organized by Innovation Centre Denmark - Munich with the aim of promoting exchange between German and Danish biotech companies in the field of innovation and knowledge transfer.    Our CEO Benedikt von Braunmühl and our COO Christiane Bardroff welcomed the visitors together with representatives from our different departments, from process science to IT. A big thank you also goes to Techvolver ApS, atSpiro, Scifeon, Inniti, UV Medico, Enabled Robotics and Baden-Württemberg International (BW_i), who presented demos and test models and set up a small showroom. The meeting was an opportunity for very interesting discussions and the exchange of expertise.  

Meet, Learn, and Discover. Our Sustainability Team recently hosted a Sustainability Day at our headquarters in Laupheim, Germany. The event offered our colleagues a fun and interactive way to test their knowledge of sustainability. They had the chance to explore their questions and ideas with the team while learning more about our ongoing initiatives. Our Sustainability Team is composed of colleagues from six different departments, united by their passion for sustainability. They dedicate time beyond their daily responsibilities to drive forward various initiatives. A big thank you goes out to all of them for their important commitment! Maximilian Ludwig, Jacqueline Perl, Hannes Ofner, Nadja Mannal, Miriam Schnösenberg, Dr. Adrian Gihring, Thomas Maier #RentschlerBiopharma #ReliabilityYouCanTrust #SustainabilityDay 

To all our colleagues, friends, clients and partners: Happy Thanksgiving from the entire Rentschler Biopharma family! #RentschlerBiopharma #ReliabilityYouCanTrust #HappyThanksgiving

Following a busy networking lunch, we returned for the next fireside chat here at #AdvancedTherapiesIntegrates. From lab to market: The CGT biotech journey. Robert Panting, General Manager, ATMP, Rentschler Biopharma spoke with Catriona Crombie, Head of Rare Disease at LifeArc on her thoughts on the approaches needed for success in the ever more challenging biotech journey. Asked for her key takeaways or advice for someone thinking about founding or in the early stages of a new biotech, Catriona responded: "I think what you need in order to be successful is to be both creative and resilient." "You've got to be able to take some of the knocks. Then think, how do I fix this? How do we get this better? And think creatively, because those that do, are the people who really succeed."